약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 6. Sensitivity analysis of adverse drug reactions related to weight loss effects of tenofovir disoproxil fumarate stratified by age
age KAERS FAERS
case % ROR 95%CI case % ROR 95%CI
0-9 0 - - - 0 - - -
10-19 0 - - - 0 - - -
20-29 0 - - - 1 0.03 0.4 0.1-2.4
30-39 0 - - - 3 0.04 1.2 0.4-3.5
40-49 2 0.47 - - 8 0.07 1.2 0.6-2.2
50-59 1 0.11 2.3 0.6-9.3 6 0.03 0.5 0.2-1.0
60-69 0 - 0 - 5 0.06 1.1 0.5-2.4
70-79 1 0.1 2.3 0.5-11.6 2 0.05 0.6 0.2-2.4
80≤ 0 - 0 - 0 - 0 -
unknown 15 0.22 1.0 0.7-1.5 26 0.04 0.2 0.2-0.3

Abbreviation: AE, Adverse event; CI, Confidence interval; FAERS, United States Food and Drug administration adverse events reporting system; KAERS, Korea adverse event reporting system; ROR, Reporting Odds Ratio.

Yakhak Hoeji 2024;68:362-70 https://doi.org/10.17480/psk.2024.68.5.362
© 2024 Yakhak Hoeji